Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model
Pagel, John M., Kenoyer, Aimee L., Bäck, Tom, Hamlin, Donald K., Wilbur, D. Scott, Fisher, Darrell R., Park, Steven I., Frayo, Shani, Axtman, Amanda, Orgun, Nural, Orozco, Johnnie, Shenoi, Jaideep, Lin, Yukang, Gopal, Ajay K., Green, Damian J., Appelbaum, Frederick R., Press, Oliver W.
Published in Blood (21.07.2011)
Published in Blood (21.07.2011)
Get full text
Journal Article
Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma
PARK, Steven I, SHENOI, Jaideep, KENOYER, Aimee L, AXTMAN, Amanda, GOPAL, Ajay K, GREEN, Damian J, PAGEL, John M, PRESS, Oliver W, FRAYO, Shani M, HAMLIN, Donald K, YUKANG LIN, SCOTT WILBUR, D, STAYTON, Patrick S, ORGUN, Nural, HYLARIDES, Mark, BUCHEGGER, Franz
Published in Clinical cancer research (01.12.2011)
Published in Clinical cancer research (01.12.2011)
Get full text
Journal Article
Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease
Park, Steven I., Shenoi, Jaideep, Pagel, John M., Hamlin, Don K., Wilbur, D. Scott, Orgun, Nural, Kenoyer, Aimee L., Frayo, Shani, Axtman, Amanda, Bäck, Tom, Lin, Yukang, Fisher, Darrell R., Gopal, Ajay K., Green, Damian J., Press, Oliver W.
Published in Blood (18.11.2010)
Published in Blood (18.11.2010)
Get full text
Journal Article
Conventional Anti-CD45 Radioimmunotherapy Comparing 90Y or 177Lu for Treatment of AML in a Syngeneic Disseminated Murine Leukemia Model
Orozco, Johnnie J., Kenoyer, Aimee, Axtman, Amanda, Frayo, Shani L., Morris, Paul J., Hamlin, Donald K., Wilbur, D. Scott, Fisher, Darrell R., Hylarides, Mark D., Green, Damian J., Gopal, Ajay K., Gooley, Ted, Press, Oliver W., Pagel, John M.
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Conventional and Pretargeted Radioimmunotherapy with Bismuth-213 to Target and Treat CD20-Expressing Non-Hodgkin Lymphoma: A Preclinical Model for Consolidation Therapy to Eradicate Minimal Residual Disease
Park, Steven I., Shenoi, Jaideep, Pagel, John M., Hamlin, Donald K., Orgun, Nural, Kenoyer, Aimee L., Wilbur, Shani M., Axtman, Amanda, Wilbur, D. Scott, Lin, Yukang, Fisher, Darrell R., Gopal, Ajay K., Green, Damian J., Press, Oliver W.
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article
Anti-CD45 Ab Pretargeted Radioimmunotherapy Using An Alpha Emitting Radionuclide (213Bi) Delivers Selective Radiation to Human Myeloid Leukemias in a Mouse Xenograft Model and Results in High Rates of Complete Remission and Long Term Survival
Kenoyer, Aimee L., Press, Oliver W., Park, Steven I., Back, Tom, Hamlin, Donald K., Wilbur, D. Scott, Fisher, Darrell R., Wilbur, Shani M., Axtman, Amanda, Orgun, Nural, Lin, Yukang, Gopal, Ajay K., Shenoi, Jaideep, Green, Damian J., Appelbaum, Frederick R, Pagel, John M.
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article
New Oreans: new visions: ALL Edition
Amanda Paulson and Kris Axtman Staff writers of the Christian Science Monitor
Published in The Christian Science monitor (1983) (12.10.2005)
Get full text
Published in The Christian Science monitor (1983) (12.10.2005)
Newspaper Article